Skip to content
Get started

Portal & Abbvie: Unlocking Intracellular Insights for Drug Discovery

Group 2 (9)
AbbVieLogo_Preferred_DarkBlue_on_white 1 (1)
Group 3 (1)-1
Webinar social card abbvie & promega (3)

Upcoming Webinar

Portal & AbbVie: Unlocking Intracellular Insights for Drug Discovery

See how Portal and Promega are enabling AbbVie to test impermeable small molecules, protein degraders, and gene editing constructs directly inside living cells — bypassing traditional permeability limitations to accelerate early drug discovery decisions.

Even if you can't attend live, register anyway and we'll send you the recording afterwards!

Watch the replay:

What You'll Learn:

  • How mechanoporation enables structure-activity relationship (SAR) studies for impermeable small molecules and protein degraders that can't cross the cell membrane on their own
  • How Portal delivers Promega's impermeable NanoBRET tracers to enable intracellular target engagement assays for mechanistic studies
  • How Portal facilitates CRISPR knock-in experiments to support functional genomics workflows
  • How Portal's technology platform provides a single solution spanning compound delivery, live-cell assays, and gene editing
Zvmp9rVsGrYSwHFg_Drug-discovery-with-portal
Group 2 (10)

Armon Sharei

Founder & CEO Portal Bio

IMG_6041

Milad Rouhimoghadam

Senior Scientist at Abbvie